Guex J-J
Cabinet de Médecine Vasculaire, 32 Bd Dubouchage, 06000 Nice, France.
Phlebology. 2009 Dec;24(6):270-4. doi: 10.1258/phleb.2009.009049.
To describe and report incidence and frequency of side-effects and complications of sclerotherapy with foamed sclerosing agents. To explain, when possible, their pathophysiology and to indicate possible manoeuvres and techniques to limit them.
Review of current literature and personal research.
Complications of foam sclerotherapy include complications of sclerotherapy in general and specific complications of foamed sclerosing agents. Side-effects related to the sclerosing compounds are also taken into account.
Complications and side-effects of careful foam sclerotherapy remain uncommon. However, more research is needed to understand them better and to further reduce their incidence. Their description to patients in the course of the informed consent is a prerequisite to any sclerosing treatment.
描述并报告泡沫硬化剂硬化治疗的副作用及并发症的发生率和频率。尽可能解释其病理生理学，并指出限制这些副作用及并发症的可能操作和技术。
回顾当前文献及个人研究。
泡沫硬化治疗的并发症包括一般硬化治疗的并发症以及泡沫硬化剂特有的并发症。还考虑了与硬化剂相关的副作用。
谨慎进行泡沫硬化治疗的并发症和副作用仍然不常见。然而，需要更多研究以更好地理解它们并进一步降低其发生率。在知情同意过程中向患者描述这些并发症和副作用是任何硬化治疗的前提条件。
